AMBALAL SARABHAI ENTERPRISES
|
The Current P/S Ratio of AMBALAL SARABHAI ENTERPRISES is 1.45.
| Share Price | ₹38.8 | Sep 22,2026 |
| Market Cap | ₹297.4 Cr | |
| Sales-TTM | ₹205.5 Cr | TTM-Consolidated Results |
| Price/Sales | 1.45x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of AMBALAL SARABHAI ENTERPRISES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹297.4 Cr] as on Sep 22,2026
(/) Sales [ ₹205.5 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 1.45x ]
Thus, for AMBALAL SARABHAI ENTERPRISES , the investors are currently willing to pay '1.45 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of AMBALAL SARABHAI ENTERPRISES !
The chart below summarizes the trend in P/S Ratio of AMBALAL SARABHAI ENTERPRISES over the last five years.
Historical PS (Price/Sales) ratio chart of AMBALAL SARABHAI ENTERPRISES
PS Ratio Performance Analysis for AMBALAL SARABHAI ENTERPRISES
- AMBALAL SARABHAI ENTERPRISES 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 1.32x.
- AMBALAL SARABHAI ENTERPRISES 's operated at median p/e ratio of 1.36x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, AMBALAL SARABHAI ENTERPRISES 's p/e ratio peaked in Mar2024 at 2.01x.
- AMBALAL SARABHAI ENTERPRISES 's p/e ratio hit its five-year low in Mar2026 of 0.92x.
How does AMBALAL SARABHAI ENTERPRISES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| AMBALAL SARABHAI ENTERPRISES | 205.5 | 1.45 | 297.4 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.38 | 442,437.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 22.09 | 248,054.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 12.07 | 189,842.0 |
| CIPLA LTD | 28,324.4 | 3.94 | 111,565.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 3.04 | 101,163.0 |
| MANKIND PHARMA LTD | 14,737.9 | 6.95 | 102,410.0 |
| LUPIN LTD | 29,966.6 | 3.24 | 96,950.0 |
| ZYDUS LIFESCIENCES LTD | 28,591.7 | 4.05 | 115,810.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.79 | 97,641.6 |
| LAURUS LABS LTD | 7,269.6 | 14.90 | 108,338.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs AMBALAL SARABHAI ENTERPRISES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 1.45x |
| Max industry PS | 22.09x |
| Median industry PS | 4.05x |
| Average industry PS | 7.45x |
You may also like the below Video Courses